University of Chicago, Investigational Drug Service Pharmacy — Chicago, Illinois

University of Chicago, Investigational Drug Service Pharmacy is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Chicago, Investigational Drug Service Pharmacy has participated in 2 clinical trials.

Therapeutic areas: Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders.

Sponsors: GlycoMimetics Incorporated, Biossil Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago, Investigational Drug Service Pharmacy?

University of Chicago, Investigational Drug Service Pharmacy has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago, Investigational Drug Service Pharmacy conducted?

University of Chicago, Investigational Drug Service Pharmacy has 2 clinical trials on record. Their work covers Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders.

Is University of Chicago, Investigational Drug Service Pharmacy accredited by Crixeo Clinical Trials?

University of Chicago, Investigational Drug Service Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago, Investigational Drug Service Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.